SHARP PHILLIP A - Insider Transactions
Insider Type
individual
Companies
1
Average
1,090,546
Total Txns
7
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 6 | -6 | 0.00 | 4,540,070.94 | -4,540,070.94 |
| 2025 | 0 | 1 | -1 | 0.00 | 3,093,750.00 | -3,093,750.00 |
| Total: | 0 | 7 | 7 | 0.00 | 7,633,820.94 | -7,633,820.94 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
275.00 USD |
11,250 Sold |
3,093,750 USD |
23/01/2025 | 23/01/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
150.60 USD |
13,005 Sold |
1,958,553 USD |
29/02/2024 | 29/02/2024 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
151.43 USD |
13,557 Sold |
2,052,937 USD |
29/02/2024 | 29/02/2024 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
152.40 USD |
915 Sold |
139,446 USD |
29/02/2024 | 29/02/2024 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
153.62 USD |
1,906 Sold |
292,800 USD |
29/02/2024 | 29/02/2024 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
154.07 USD |
101 Sold |
15,561 USD |
29/02/2024 | 29/02/2024 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
156.54 USD |
516 Sold |
80,775 USD |
29/02/2024 | 29/02/2024 |